José Roberto Filassi

José Roberto Filassi

Auto-generated profile, based on publicly available information

José Roberto Filassi

Universidade de São Paulo, Brazil

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 March 2025 in Clinics
Verified
Journal Article
Open access
ADAline Rocha Donato
Aline Rocha Donato
RGRodrigo Goncalves
Rodrigo Goncalves
JMJonathan Yugo Maesaka
Jonathan Yugo Maesaka
FAFernando Nalesso Aguiar
Fernando Nalesso Aguiar
José Maria  Soares-JrJosé Maria Soares-Jr
José Maria Soares-Jr
EBEdmund Chada Baracat
Edmund Chada Baracat
Phyllodes Tumor (PT) of the breast is a rare type of fibroepithelial neoplasm, classified into benign, borderline, and malignant subtypes. These tumors are known to be locally aggressive and have an inherent potential for Local Recurrence (LR), even after adequate surgical treatment. Establishing strategies to reduce LR has become increasingly important, as 21 % to 36 % of patients experience disease recurrence despite achieving negative surgical margins. Although surgical resection of the lesion is the gold standard treatment for all subtypes of phyllodes tumors, the ideal extent of the surgical margin remains a topic of debate with no consensus in the literature. Adjuvant radiotherapy is suggested as a tool to improve local control of the disease and reduce the recurrence rate; however, published data on this approach are currently conflicting. In this review paper, the authors will provide a detailed analysis of the current evidence on the diagnosis, treatment, follow-up, outcomes, and future perspectives of phyllodes tumors.

1 September 2012 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
MRMarcos Desidério Ricci
Marcos Desidério Ricci
CFCarlos Marino Cabral Calvano Filho
Carlos Marino Cabral Calvano Filho
HFHelio Rubens de Oliveira Filho
Helio Rubens de Oliveira Filho
JFJosé Roberto Filassi
José Roberto Filassi
JPJosé Aristodemo Pinotti
José Aristodemo Pinotti
EBEdmund Chada Baracat
Edmund Chada Baracat
Objective: To evaluate whether immunohistochemical marker studies performed on core needle biopsy (CNB) specimens accurately reflect the marker status of the tumor obtained from final surgical specimen. Methods: This was a retrospective study that used the database of the Division of Mastology of the Hospital das Clinicas, Sao Paulo, Brazil. Sixty-nine patients submitted to ultrasound-guided CNB diagnosed with breast cancer were retrospectively analyzed. Immunohistochemistry (IHC) on core biopsy specimens was compared to that of excisional biopsy regarding estrogen receptor (ER), progesterone receptor (PR), human epidermal gowth factor receptor 2 gene (HER2), p53, and Ki67. The analysis of the concordance between CNB and surgical biopsy was performed using the kappa (k) coefficient (95% CI). Results: A perfect concordance between the labeling in the surgical specimens and the preoperative biopsies in p53 (k = 1.0; 95% CI: 0.76-1.0) was identified. There was an almost perfect concordance for ER (k = 0.89; 95% CI: 0.65-1.0) and a substantial concordance for PR (k = 0.70; 95% CI: 0.46-0.93). HER2 (k = 0.61; 95% CI: 0.38-0.84) and Ki-67 (k = 0.74; 95% CI: 0.58-0.98) obtained a substantial concordance this analysis. Conclusion: The results of this study indicate that the immunohistochemical analysis of ER, PR, Ki-67, and p53 from core biopsy specimens provided results that accurately reflect the marker status of the tumor. The concordance rate of HER2 was less consistent; although it produced substantial concordance, values were very close to moderate concordance.OBJETIVO: Avaliar se a análise dos marcadores imunoistoquímicos obtidos por meio de espécimes de core biopsy (CB) refletem com precisão o perfil dos marcadores tumorais obtidos por biópsia cirúrgica excisional (BCE). \ud MÉTODOS: Estudo retrospectivo usando dados da Divisão de Mastologia do Hospital das Clínicas de São Paulo. Sessenta e nove pacientes submetidas à CB guiada por ultrassom com diagnóstico de câncer de mama foram analisadas retrospectivamente. O exame imunoistoquímico dos espécimes de CB foram comparados com aquele obtido a partir da BCE em relação ao receptor de estrogênio (RE), receptor de progesterona (RP), human epidermal gowth factor receptor 2 gene (HER2), p53 e Ki-67. A análise de concordância entre a CB e a BCE foram realizados usando o coeficiente de kappa (k) (IC 95%). \ud RESULTADOS: A concordância perfeita entre a BCE e a CB do p53 (k = 1,0; IC 95%: 0,76-1,0) foi identificada. A concordância foi quase perfeita para o RE (k = 0,89; IC 95%: 0,65-1,0) e concordância substancial foi identificada para o RP (= 0,70; IC 95%: 0,46-0,93). O HER2 (k = 0,61; IC 95%: 0,38-0,84) e Ki-67 (k = 0,74; IC 95%: 0,58-0,98) obtiveram uma concordância substancial nesta análise. \ud CONCLUSÃO: os resultados deste estudo indicam que a análise imunoistoquímica do RE, RP, Ki-67 e p53 a partir dos espécimes de CB fornecem resultados que refletem com precisão o perfil dos marcadores do tumor. O HER2 foi menos consistente, porque apesar de ter produzido uma concordância substancial, os valores foram muito próximos da concordância moderada

10 June 2023 in Clinics
Verified
Journal Article
Open access
JMJonathan Yugo Maesaka
Jonathan Yugo Maesaka
YRYedda Nunes Reis
Yedda Nunes Reis
LELivia Menezes Elias
Livia Menezes Elias
DADenise Akerman
Denise Akerman
EBEdmund Chada Baracat
Edmund Chada Baracat
JFJosé Roberto Filassi
José Roberto Filassi
Venous Thromboembolism (VTE) is an important cause of morbidity in cancer patients. Breast cancer patients undergoing surgical treatment are at an increased risk of VTE. The aim of this study was to determine the frequency of VTE in patients who underwent surgery for the treatment of breast cancer and to identify the related risk factors. A historical cohort of patients at the São Paulo State Cancer Institute (ICESP) underwent surgery for breast cancer. The inclusion criteria covered patients with invasive breast cancer or ductal carcinoma in situ who had breast surgery anytime from January 2016 to December 2018. Of the 1672 patients included in the study, 15 had a confirmed diagnosis of VTE (0.9%), and 3 of these had deep vein thrombosis (0.2%), and 12, had pulmonary thromboembolism (0.7%). Clinical and tumoral characteristics did not differ between the groups. The incidence of VTE was higher in patients who had undergone skin-sparing mastectomy or nipple-sparing mastectomy (p = 0.032). Immediate reconstruction, particularly with abdominal-based flaps (4.7%), increased VTE events (p = 0.033). Median surgical time was higher in patients with VTE episodes (p = 0.027), and total hospital length of stay increased in days (6 days vs. 2 days, p = 0.001). Neoadjuvant chemotherapy and postoperative prophylaxis with Low Molecular Weight Heparin (LMWH) were associated with lower VTE rates (0.2% vs. 1.2%, p = 0.048 and 0.7% vs. 2.7%, p = 0.039; respectively) in these patients. The incidence of VTE events in breast cancer patients who underwent surgery was 0.9%. Immediate reconstruction (especially with abdominal-based flaps), skin-sparing/nipple-sparing mastectomies, and longer surgeries were associated with increased risk. The LMWH postoperative prophylaxis reduced this risk.

1 January 2021 in Clinics
Verified
Journal Article
Open access
YRYedda Nunes Reis
Yedda Nunes Reis
JMJonathan Yugo Maesaka
Jonathan Yugo Maesaka
CSCarlos Shimizu
Carlos Shimizu
José Maria  Soares-JrJosé Maria Soares-Jr
José Maria Soares-Jr
EBEdmund Chada Baracat
Edmund Chada Baracat
JFJosé Roberto Filassi
José Roberto Filassi
This study aimed to evaluate the clinical and imaging predictive factors for the diagnosis of phyllodes tumors in patients with inconclusive results from core needle biopsy (fibroepithelial lesions). We retrospectively analyzed data of patients who underwent surgical excision of breast lesions previously diagnosed as fibroepithelial lesions. Numeric variables were analyzed using the Shapiro-Wilk and t-tests, and categorical variables were analyzed using the chi-square and Fisher’s exact tests. Multivariate logistic regression was performed to calculate odds ratios and detect predictive factors for the diagnosis of PT. A total of 89 biopsy samples were obtained from 77 patients, of which 43 were confirmed as fibroadenomas, 43 as phyllodes tumors, and 3 as other benign, non-fibroepithelial breast lesions. The mean tumor size was 3.61 cm (range, 0.8-10 cm) for phyllodes tumors and 2.4 cm (range, 0.8-7.9 cm) for fibroadenomas. The predictive factor for phyllodes tumor diagnosis was lesion size >3 cm (p<0.001). Our data indicate that fibroepithelial lesions of the breast larger than 3 cm are more likely to be phyllodes tumors.

1 December 2015 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
PDF file
ANAfonso Celso Pinto Nazário
Afonso Celso Pinto Nazário
GIL FACINAGIL FACINA
GIL FACINA
JFJosé Roberto Filassi
José Roberto Filassi
The authors discuss the main innovations in the diagnosis and treatment of breast cancer, particularly in diagnostic imaging and screening, and in locoregional and systemic therapies.

1 January 2023 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
José Maria  Soares-JrJosé Maria Soares-Jr
José Maria Soares-Jr
BMBruna Salani Mota
Bruna Salani Mota
GNGabriela Bezerra Nobrega
Gabriela Bezerra Nobrega
JFJosé Roberto Filassi
José Roberto Filassi
Isabel SorpresoIsabel Sorpreso
Isabel Sorpreso
EBEdmund Chada Baracat
Edmund Chada Baracat